Rajeev Agarwal, M.D. – FDA Inspection, Jan 5, 2017

Record Details

This FDA Inspection record concerns Rajeev Agarwal, M.D., with an inspection on January 5, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.

Company: Rajeev Agarwal, M.D.
Inspection Date: January 5, 2017
Product Type: Drugs
Office: Center for Drug Evaluation and Research
Person: Janete F. Guardia (Issuing Officer)

View Company Profile

ID · 4a51556f-4340-47c0-8194-988767dfbc25

Inspection Facts

Voluntary Action Indicated (VAI)

Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.

Inspection number: 1000900
FDA center: Human Drugs
Project area: Bioresearch Monitoring
Outcome: Form 483 issued

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Rajeev Agarwal, M.D.

FDA Inspection

Rajeev Agarwal, M.D.January 5, 2017